Oct 3, 2014, 00:00 AM by Michael Croft

ROCHESTER, NY, UNITED STATES - Oct 3, 2014 - Clinical Conductor CTMS, the leading clinical trial management system, and OpenClinica, one of the world's most widely adopted electronic data capture (EDC) software platforms, are pleased to announce the formation of a strategic partnership to deliver a seamless EDC-CTMS integration to drive productivity in clinical research

Oct 2, 2014, 08:00 AM by Michael Croft

Bio-IT World | News and product releases from around the industry, including early-stage pharma startups supported by GSK and Avalon Ventures, and the Eaglecore cloud knowledge management platform.

Oct 1, 2014, 08:55 AM by Michael Croft

Bio-IT World | The U-BIOPRED Consortium, an international project searching for novel biomarkers to better define severe asthma cases, received a Bio-IT World Best Practices Award this spring for its far-reaching implementation of the tranSMART knowledge management platform.

Oct 1, 2014, 00:00 AM by Michael Croft

ROCHESTER, NY, UNITED STATES - Oct 1, 2014 - Clinical Conductor CTMS, the leading clinical trial management system, and OpenClinica, one of the world's most widely adopted electronic data capture (EDC) software platforms, are pleased to announce the formation of a strategic partnership to deliver a seamless EDC-CTMS integration to drive productivity in clinical research

Oct 1, 2014, 00:00 AM by Michael Croft

SAN FRANCISCO, CA - Oct 1, 2014 - Databiology Inc., a global life sciences software and services company, announced today that the genetic variant knowledge-base and genome interpretation capabilities of Tute Genomics Inc

Sep 30, 2014, 10:40 AM by Michael Croft

Bio-IT World News Brief | This morning, the NIH announced the recipients of its first round of grants tied to the nationwide BRAIN Initiative, totaling $46 million in funding for research meant to develop an integrated understanding of human brain function.

Sep 30, 2014, 00:00 AM by Michael Croft

SAN MATEO, CA - Sep 30, 2014 - Maverix Biomics Inc., a leading genomic analysis software company, today announced that Jim Bristow, M

Sep 30, 2014, 00:00 AM by Michael Croft

CHAPEL HILL, NC, UNITED STATES - Sep 30, 2014 -   WHAT:  Rho, a full-service contract research organization (CRO), is showcasing its 30-year history of success in drug development strategies and services, including risk-based monitoring (RBM) strategies, at the Outsourcing in Clinical Trials (OCT) New England Conference taking place October 7-8 in Boston, Massachusetts

Sep 29, 2014, 08:10 AM by Michael Croft

Bio-IT World News Brief | Transcriptic, the programmable lab-for-hire, has moved to a new, 10,000-square foot location as it adds more instruments and "work cells" where experiments are conducted.

Sep 29, 2014, 00:00 AM by Michael Croft

BOULDER, CO, UNITED STATES - Sep 29, 2014 -  Final results from a Phase 2 trial of binimetinib in patients with advanced NRAS mutant melanoma were presented today at the European Society for Medical Oncology (ESMO) Annual Meeting in Madrid, Spain

Sep 29, 2014, 00:00 AM by Michael Croft

PHILADELPHIA, PA, UNITED STATES - Sep 29, 2014 - The Intellectual Property and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced the release of Biosimilars: A Global Perspective of a New Market – Opportunities, Threats and Critical Strategies 2014

Sep 26, 2014, 08:55 AM by Michael Croft

Bio-IT World News Brief | Researchers at the Broad Institute of MIT and Harvard have created a line of mice whose cells naturally express the Cas9 protein used in CRISPR gene editing, which can be used for virtually any gene knockdown experiment.

Sep 26, 2014, 00:00 AM by Michael Croft

PHILADELPHIA, PA, UNITED STATES - Sep 26, 2014 - The Intellectual Property &  Science business of Thomson Reuters, the world leader in intelligent information for businesses and professionals, announced its 2014 “Nobel-class” Citation Laureates  today

Sep 25, 2014, 13:35 PM by Michael Croft

Bio-IT World News Brief | Just two days after launching a Kickstarter campaign to start the world's first brokerage service for personal whole genome sequencing, GeneHub has pulled the plug.

Sep 25, 2014, 09:35 AM by Michael Croft

Bio-IT World News Brief | Francis de Souza, president of gene sequencing company Illumina, spoke at the EmTech conference in Cambridge this week about his company's pivot to clinical use, and a growing market for whole genome sequencing that he says will produce 228,000 whole human genomes in 2014 alone.

Sep 25, 2014, 00:00 AM by Michael Croft

TORONTO, CANADA - Sep 25, 2014 - Chemical libraries for a long time have been a cornerstone in the search for new pharmaceutical compounds

Sep 24, 2014, 08:55 AM by Michael Croft

Bio-IT World News Brief | San Francisco-based GeneHub has plans to become the first company selling whole genome sequences to all comers, and launched a Kickstarter campaign this week to raise the funds it needs to get started.

Sep 24, 2014, 00:00 AM by Michael Croft

BISHOP'S STORTFORD, UK - Sep 24, 2014 - ~~Dotmatics, a leading provider of scientific informatics solutions and services, announced today that this year’s European User Group Meeting (EUGM) held at Down Hall Country House Hotel, Hertfordshire was the largest and most successful to date

Sep 24, 2014, 00:00 AM by Michael Croft

NEEDHAM, MA - Sep 24, 2014 - Cambridge Healthtech Institute Announces the Acquisition of OpenHelixProvider of online and onsite bioinformatics training to join Cambridge Healthtech Institute as division of Bio-IT World Cambridge Healthtech Institute (CHI) announced the purchase of Washington-based OpenHelix, the provider of online and onsite training on some of the most popular and powerful open-access bioinformatics resources on the web

Sep 23, 2014, 12:15 PM by Michael Croft

Clinical Informatics News | As the FDA extends its oversight to tests designed and performed in a single laboratory, diagnostic companies are celebrating a more even playing field. But hospital and academic labs worry that the high price tag of FDA review will stifle their in-house tests without protecting patients.